Antibacterial and antifungal peptides

Inactive Publication Date: 2010-07-22
C3 JIAN LLC
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0050]“Treating” or “treatment” of a condition as used herein may refer to preventing the condition, slowing the onset or rate of development of the condition, reducing the risk of developing the condition, preventing o

Problems solved by technology

However, in recent years, the trend in reducing infectious disease mortality has been threatened by the emergence of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibacterial and antifungal peptides

Examples

Experimental program
Comparison scheme
Effect test

Example

Example 1

Synthesis and Screening of Antimicrobial Peptides

[0221]Peptides were synthesized utilizing standard solid-phase synthesis methods (Fmoc or Boc chemistries). In certain embodiments, peptides were synthesized using Fmoc (9-fluorenylmethoxy carbonyl) solid-phase synthesis utilizing single or double coupling cycles at 0.01 to 0.25 mmol scales. Briefly, N-terminal deprotection was conducted in 20% (v / v) piperidine / N-methylpyrrolidone (NMP) for 3 min followed by eight washes with NMP. For the coupling cycle, amino acids were solubilized in 0.45 M N-hydroxybenzotriazole (HOBt) / HBTU (O-benzotriazole-N,N,N,N-tetramethyl-uronium hexafluoro-phosphate) in dimethylformamide (DMF) with 0.9 M diisopropyl ethylamine (DIEA) (1:1:1:2 ratio Fmoc amino acid:HOB:HBTU:DIEA) before being added to the resin for 30 min, followed by 10 NMP rinses. As needed, peptides were then labeled N-terminally with 4-molar excess fluorescent dyes or blocking groups in HOBt / HBTU / DIEA coupling solution with shakin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molar densityaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

This invention provides novel antimicrobial peptides and formulations thereof. The peptides and/or formulations are effective to kill or to inhibit the growth and/or proliferation of various bacteria, yeast, and fungi.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims benefit of and priority to U.S. Ser. No. 61 / 142,830, filed Jan. 6, 2009, U.S. Ser. No. 61 / 151,445, filed Feb. 10, 2009, U.S. Ser. No. 61 / 243,905, filed Sep. 18, 2009, and U.S. Ser. No. 61 / 243,930, filed Sep. 18, 2009, all of which are incorporated herein by reference in their entirety for all purposes.STATEMENT OF GOVERNMENTAL SUPPORT[0002][Not Applicable]FIELD OF THE INVENTION[0003]The present invention relates to the fields of antibiotics and pharmacology. More particularly this invention pertains to the identification of novel antimicrobial peptides (AMPs) that have activity against a number of bacteria and / or fungi.BACKGROUND OF THE INVENTION[0004]The development of antimicrobial agents led to a significant decrease in morbidity and mortality from infectious diseases in this century. This accomplishment was largely due to the widespread use of the major classes of antibiotics, such as the sulfonamides, penicill...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/16C07K14/00C07K7/08C07K7/06A61K38/10A01N37/18A61K38/08C07K16/00A61P31/04A01P1/00
CPCA61K8/64Y02A50/473A61K9/0063A61K9/06A61K38/08A61K38/10A61K38/16A61K41/0009A61K41/0057A61K47/10A61K47/26A61K47/34A61Q11/00A01N37/46C07K7/06C07K7/08C07K14/001A61K41/0071G01N33/569A61K47/6911A61K47/64Y02A50/47A61K9/0019A61K41/10A61P31/00A61P31/04A61P31/10Y02A50/30
Inventor ECKERT, RANDAL H.KAPLAN, CHRISHE, JIANYARBROUGH, DANIEL K.ANDERSON, MAXWELLSIM, JEE-HYUN
Owner C3 JIAN LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products